Antihypertensive therapy--going to the heart of the matter.-Reference-Cited by-同舟云学术

Antihypertensive therapy--going to the heart of the matter.

Published:1990-03 Issue:3 Volume:81 Page:1128-1135
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Messerli F H¹

Affiliation:

1. Department of Internal Medicine, Ochsner Clinic, New Orleans, Louisiana.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.81.3.1128

Reference109 articles.

1. The Heart in Hypertension

2. Frohlich ED: The heart in hypertension in Genest I Kuchel 0 Hamet P Cantin M (eds): Hypertension: Physiopathology and Treatment ed 2. New York McGraw-Hill Book Co 1983 pp 791-810

3. Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy;Tarazi RC;Circulation,1987

4. Messerli FH: The Heart in Hypertension. New York Yorke Medical Books 1987 p 27

5. Left ventricular wall stress and systolic function in untreated primary hypertension.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension;Journal of Cardiac Failure;2010-07

2. Gene Polymorphism of Myospryn (Cardiomyopathy-Associated 5) Is Associated with Left Ventricular Wall Thickness in Patients with Hypertension;Hypertension Research;2007

3. Franz H. Messerli, MD: A Conversation With the Editor⁎⁎This series of interviews is underwritten by an unrestricted grant from Bristol-Myers Squibb.;The American Journal of Cardiology;2005-07

4. The LIFE study: the straw that should break the camel's back;European Heart Journal;2003-03

5. Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [life] study);The American Journal of Cardiology;2002-11